SpecGx recalls 100-tablet opioid pain relief with possible missing tablet imprints. Consumers should check for missing imprints and contact the manufacturer for details.
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
SpecGx is recalling opioid pain medication that may have missing tablet imprints. This could lead to confusion about the medication's identity, potentially causing incorrect use or safety issues.
The tablets may have missing imprints, making it difficult to identify the medication correctly. This could lead to incorrect use or safety issues if someone takes the wrong medication.
Prescription holders of the 100-tablet opioid pain medication with missing imprints. People who take these medications regularly are most at risk of confusion.
Check for missing imprints on the tablets. The product was sold with NDC 0406-0523-01 and lots 0523J23904 (expires 05/2027) or 0523J24426, 0523J24427 (expires 06/2027).
Look for missing imprints on the tablets to identify if the product is recalled.
The recall is due to a potential missing tablet imprint, which could cause confusion but does not pose a direct safety risk in normal use.
Check for missing imprints on the tablets. The product was sold with NDC 0406-0523-01 and lots 0523J23904 (expires 05/2027) or 0523J24426, 0523J24427 (expires 06/2027).
Check for missing imprints and contact SpecGx for further instructions.
We’ve drafted a message you can send SpecGx to request your refund or repair — edit it as you like.
Subject: Recall D-0254-2026 — SpecGx SpecGx Hello, I own a SpecGx that is covered by recall D-0254-2026 from SpecGx. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.